Fennec Pharmaceuticals (FENC) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free FENC Stock Alerts $9.42 +0.15 (+1.62%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFennec Pharmaceuticals (FENC) Scheduled to Post Quarterly Earnings on Tuesdaymarketbeat.com - May 8 at 10:17 AMFennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024globenewswire.com - May 7 at 6:15 PMFennec Pharmaceuticals Inc Forecasted to Post Q4 2024 Earnings of $0.06 Per Share (NASDAQ:FENC)americanbankingnews.com - May 6 at 2:56 AMRosty Raykov Sells 2,431 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stockamericanbankingnews.com - May 4 at 6:16 AMFennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Sells $22,146.41 in Stockinsidertrades.com - May 3 at 8:03 AMAdrian Haigh Sells 22,223 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stockinsidertrades.com - April 23 at 5:00 AMFennec Pharmaceuticals Inc (NASDAQ:FENC) COO Adrian Haigh Sells 22,222 Sharesinsidertrades.com - April 23 at 4:22 AMFennec Pharmaceuticals Inc (NASDAQ:FENC) COO Sells $207,118.36 in Stockmarketbeat.com - April 22 at 9:20 PMFennec Pharmaceuticals COO sells shares worth over $536kinvesting.com - April 20 at 11:00 PMFennec Pharmaceuticals Inc (NASDAQ:FENC) COO Sells $220,220.02 in Stockinsidertrades.com - April 19 at 6:53 AMFennec Pharmaceuticals Inc (NASDAQ:FENC) COO Sells $228,886.60 in Stockinsidertrades.com - April 18 at 6:32 AMThose who invested in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago are up 136%finance.yahoo.com - April 9 at 2:14 PMFennec Pharmaceuticals CEO sells shares worth over $950kuk.investing.com - April 7 at 11:51 PMInsider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Sells 44,300 Shares of Stockinsidertrades.com - April 6 at 7:31 AMFennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Rosty Raykov Sells 44,300 Sharesmarketbeat.com - April 5 at 6:39 PMHC Wainwright Comments on Fennec Pharmaceuticals Inc's Q2 2024 Earnings (NASDAQ:FENC)marketbeat.com - April 5 at 8:22 AMRosty Raykov Sells 40,584 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stockinsidertrades.com - April 5 at 5:10 AMBuy Rating Reaffirmed for Fennec Pharmaceuticals Following Strategic European Licensing Deal and Strong Financial Outlookmarkets.businessinsider.com - April 4 at 5:55 PMFennec Pharmaceuticals (NASDAQ:FENC) PT Raised to $18.00 at HC Wainwrightmarketbeat.com - April 4 at 8:30 AMInsider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Sells 40,584 Shares of Stockmarketbeat.com - April 3 at 6:43 PMFennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells $23,190.58 in Stockinsidertrades.com - March 28 at 8:47 AMChief Financial Officer Robert Andrade Sells 13,975 Shares of Fennec Pharmaceuticals Inc (FENC)finance.yahoo.com - March 27 at 7:33 PMFennec Pharmaceuticals Inc (NASDAQ:FENC) CFO Sells $153,725.00 in Stockinsidertrades.com - March 26 at 4:44 AMChief Financial Officer Robert Andrade Sells Shares of Fennec Pharmaceuticals Inc (FENC)finance.yahoo.com - March 26 at 3:23 AMInsider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CFO Sells 13,975 Shares of Stockmarketbeat.com - March 25 at 9:31 PMBuy Rating for Fennec Pharmaceuticals Amidst Strong Pedmark Sales and Market Expansion Potentialmarkets.businessinsider.com - March 22 at 8:46 AMQ4 2023 Fennec Pharmaceuticals Inc Earnings Callfinance.yahoo.com - March 22 at 8:46 AMEquities Analysts Set Expectations for Fennec Pharmaceuticals Inc's Q3 2024 Earnings (NASDAQ:FENC)marketbeat.com - March 22 at 8:18 AMFENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023investorplace.com - March 21 at 3:03 PMFennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Updateglobenewswire.com - March 21 at 6:00 AMFennec Pharmaceuticals (FENC) Set to Announce Quarterly Earnings on Thursdaymarketbeat.com - March 20 at 3:04 PMWedbush Comments on Fennec Pharmaceuticals Inc's FY2024 Earnings (NASDAQ:FENC)marketbeat.com - March 20 at 6:39 AMRTP firm inks licensing deal for European drug launchbizjournals.com - March 19 at 8:07 AMWedbush Comments on Fennec Pharmaceuticals Inc's Q2 2024 Earnings (NASDAQ:FENC)marketbeat.com - March 19 at 6:55 AMFennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024globenewswire.com - March 19 at 6:01 AMFennec Pharmaceuticals (NASDAQ:FENC) PT Raised to $18.00 at Craig Hallummarketbeat.com - March 18 at 4:32 PMFennec Pharmaceuticals' (FENC) "Outperform" Rating Reaffirmed at Wedbushmarketbeat.com - March 18 at 12:20 PMFennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealandglobenewswire.com - March 17 at 9:00 PMFENC Apr 2024 12.500 callfinance.yahoo.com - March 16 at 5:59 AMNearly 1,000 Family Dollar stores are closing, owner Dollar Tree announcesmsn.com - March 14 at 9:15 PM'Milli Vanilli' Review: A Captivating and Moving Documentarynz.finance.yahoo.com - March 13 at 6:04 PMAnalysts Are Optimistic We'll See A Profit From Fennec Pharmaceuticals Inc. (NASDAQ:FENC)finance.yahoo.com - March 13 at 1:04 PMFennec Pharmaceuticals: Great Sales Progress - Not Yet Reflected In Stock Priceseekingalpha.com - March 6 at 10:23 PMBuy Rating for Fennec Pharmaceuticals Amid Strong Pedmark Sales and Market Expansion Potentialmarkets.businessinsider.com - March 1 at 8:52 AMFennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Resultsfinanznachrichten.de - February 29 at 10:02 AMFennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Resultsglobenewswire.com - February 29 at 7:04 AMFennec Pharma Says FDA Suggested Not To Substitute Pedmark With Sodium Thiosulfatemarkets.businessinsider.com - February 1 at 8:14 AMFDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatinfinance.yahoo.com - February 1 at 8:14 AMInsider Sell: CFO Robert Andrade Sells 30,000 Shares of Fennec Pharmaceuticals Incgurufocus.com - January 6 at 1:06 AMFennec Pharmaceuticals Inc (NASDAQ:FENC) Sees Significant Growth in Short Interestmarketbeat.com - January 4 at 12:10 AM Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. FENC Media Mentions By Week FENC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FENC News Sentiment▼1.030.44▲Average Medical News Sentiment FENC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FENC Articles This Week▼81▲FENC Articles Average Week Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Coherus BioSciences News Sutro Biopharma News Agenus News Metagenomi News Adaptimmune Therapeutics News Compass Therapeutics News Candel Therapeutics News Poseida Therapeutics News Monte Rosa Therapeutics News Century Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FENC) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap Profits[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
